Literature DB >> 30102520

Generation and Comparative Kinetic Analysis of New Glycosynthase Mutants from Streptococcus pyogenes Endoglycosidases for Antibody Glycoengineering.

Xin Tong1, Tiezheng Li1, Chao Li1, Lai-Xi Wang1.   

Abstract

Chemoenzymatic glycan remodeling by endoglycosidase-catalyzed deglycosylation and reglycosylation is emerging as an attractive approach for producing homogeneous glycoforms of antibodies, and the success of this approach depends on the discovery of efficient endoglycosidases and their glycosynthase mutants. We report in this paper a systematic site-directed mutagenesis of an endoglycosidase from Streptococcus pyogenes (Endo-S) at the critical Asp-233 (D233) site and evaluation of the hydrolysis and transglycosylation activities of the resulting mutants. We found that in addition to the previously identified D233A and D233Q mutants of Endo-S, most of the Asp-233 mutants discovered here were also glycosynthases that demonstrated glycosylation activity using glycan oxazoline as the donor substrate with diminished hydrolytic activity. The glycosynthase activity of the resultant mutants varied significantly depending on the nature of the amino acid substituents. Among them, the D233M mutant was identified as the most efficient glycosynthase variant with the highest transglycosylation/hydrolysis ratio, which is similar to the recently reported D184M mutant of Endo-S2, another S. pyogenes endoglycosidase. Kinetic studies of the D233M and D233A mutants of Endo-S, as well as glycosynthase mutants D184M and D184A of Endo-S2, indicated that the enhanced catalytic efficacy of the Asp-to-Met mutants of both enzymes was mainly due to an increased turnover number (increased kcat) for the glycan oxazoline substrate and the significantly enhanced substrate affinity (as judged by the reduced KM value) for the antibody acceptor.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30102520      PMCID: PMC6202118          DOI: 10.1021/acs.biochem.8b00719

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry.

Authors:  Petra Olivova; Weibin Chen; Asish B Chakraborty; John C Gebler
Journal:  Rapid Commun Mass Spectrom       Date:  2008       Impact factor: 2.419

2.  Role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin - F(ab')₂ versus Fc sialylation.

Authors:  I Schwab; F Nimmerjahn
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 3.  The impact of glycosylation on the biological function and structure of human immunoglobulins.

Authors:  James N Arnold; Mark R Wormald; Robert B Sim; Pauline M Rudd; Raymond A Dwek
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

4.  Enzymatic removal of N-glycans by PNGase F coated magnetic microparticles.

Authors:  Judit Bodnar; Akos Szekrenyes; Marton Szigeti; Gabor Jarvas; Jana Krenkova; Frantisek Foret; Andras Guttman
Journal:  Electrophoresis       Date:  2016-03-15       Impact factor: 3.535

5.  Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor.

Authors:  Kevin M Cox; Jason D Sterling; Jeffrey T Regan; John R Gasdaska; Karen K Frantz; Charles G Peele; Amelia Black; David Passmore; Cristina Moldovan-Loomis; Mohan Srinivasan; Severino Cuison; Pina M Cardarelli; Lynn F Dickey
Journal:  Nat Biotechnol       Date:  2006-11-26       Impact factor: 54.908

6.  Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.

Authors:  Rinpei Niwa; Shigeki Hatanaka; Emi Shoji-Hosaka; Mikiko Sakurada; Yukari Kobayashi; Aya Uehara; Haruhiko Yokoi; Kazuyasu Nakamura; Kenya Shitara
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

7.  Mass spectrometric kinetic analysis of human tyrosylprotein sulfotransferase-1 and -2.

Authors:  Lieza M Danan; Zhihao Yu; Adam J Hoffhines; Kevin L Moore; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-01       Impact factor: 3.109

8.  Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling.

Authors:  Tiezheng Li; Xin Tong; Qiang Yang; John P Giddens; Lai-Xi Wang
Journal:  J Biol Chem       Date:  2016-06-10       Impact factor: 5.157

9.  EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.

Authors:  Jonathan Sjögren; Eoin F J Cosgrave; Maria Allhorn; Maria Nordgren; Stephan Björk; Fredrik Olsson; Sarah Fredriksson; Mattias Collin
Journal:  Glycobiology       Date:  2015-07-08       Impact factor: 4.313

10.  Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S.

Authors:  Beatriz Trastoy; Erik Klontz; Jared Orwenyo; Alberto Marina; Lai-Xi Wang; Eric J Sundberg; Marcelo E Guerin
Journal:  Nat Commun       Date:  2018-05-14       Impact factor: 14.919

View more
  1 in total

Review 1.  Structural insights into the mechanisms and specificities of IgG-active endoglycosidases.

Authors:  Jonathan J Du; Erik H Klontz; Marcelo E Guerin; Beatriz Trastoy; Eric J Sundberg
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.